268 related articles for article (PubMed ID: 17478737)
1. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
Castellanos M; Sobrino T; Millán M; García M; Arenillas J; Nombela F; Brea D; Perez de la Ossa N; Serena J; Vivancos J; Castillo J; Dávalos A
Stroke; 2007 Jun; 38(6):1855-9. PubMed ID: 17478737
[TBL] [Abstract][Full Text] [Related]
2. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
Castellanos M; Leira R; Serena J; Blanco M; Pedraza S; Castillo J; Dávalos A
Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
[TBL] [Abstract][Full Text] [Related]
3. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA.
Moldes O; Sobrino T; Millán M; Castellanos M; Pérez de la Ossa N; Leira R; Serena J; Vivancos J; Dávalos A; Castillo J
Stroke; 2008 Jul; 39(7):2006-10. PubMed ID: 18436890
[TBL] [Abstract][Full Text] [Related]
4. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
Montaner J; Molina CA; Monasterio J; Abilleira S; Arenillas JF; Ribó M; Quintana M; Alvarez-Sabín J
Circulation; 2003 Feb; 107(4):598-603. PubMed ID: 12566373
[TBL] [Abstract][Full Text] [Related]
6. MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death.
Inzitari D; Giusti B; Nencini P; Gori AM; Nesi M; Palumbo V; Piccardi B; Armillis A; Pracucci G; Bono G; Bovi P; Consoli D; Guidotti M; Nucera A; Massaro F; Micieli G; Orlandi G; Perini F; Tassi R; Tola MR; Sessa M; Toni D; Abbate R;
Stroke; 2013 Oct; 44(10):2901-3. PubMed ID: 23908067
[TBL] [Abstract][Full Text] [Related]
7. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
Castellanos M; Leira R; Serena J; Pumar JM; Lizasoain I; Castillo J; Dávalos A
Stroke; 2003 Jan; 34(1):40-6. PubMed ID: 12511748
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.
Foerch C; Wunderlich MT; Dvorak F; Humpich M; Kahles T; Goertler M; Alvarez-Sabín J; Wallesch CW; Molina CA; Steinmetz H; Sitzer M; Montaner J
Stroke; 2007 Sep; 38(9):2491-5. PubMed ID: 17673718
[TBL] [Abstract][Full Text] [Related]
9. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
Tsuruoka A; Atsumi C; Mizukami H; Imai T; Hagiwara Y; Hasegawa Y
J Stroke Cerebrovasc Dis; 2014; 23(10):2894-2899. PubMed ID: 25282183
[TBL] [Abstract][Full Text] [Related]
10. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.
Millan M; Sobrino T; Castellanos M; Nombela F; Arenillas JF; Riva E; Cristobo I; García MM; Vivancos J; Serena J; Moro MA; Castillo J; Dávalos A
Stroke; 2007 Jan; 38(1):90-5. PubMed ID: 17138950
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
Montaner J; Alvarez-Sabín J; Molina CA; Anglés A; Abilleira S; Arenillas J; Monasterio J
Stroke; 2001 Dec; 32(12):2762-7. PubMed ID: 11739970
[TBL] [Abstract][Full Text] [Related]
12. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.
Serena J; Blanco M; Castellanos M; Silva Y; Vivancos J; Moro MA; Leira R; Lizasoain I; Castillo J; Dávalos A
Stroke; 2005 Sep; 36(9):1921-6. PubMed ID: 16100032
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.
Ramos-Fernandez M; Bellolio MF; Stead LG
J Stroke Cerebrovasc Dis; 2011; 20(1):47-54. PubMed ID: 21044610
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
Kelly PJ; Morrow JD; Ning M; Koroshetz W; Lo EH; Terry E; Milne GL; Hubbard J; Lee H; Stevenson E; Lederer M; Furie KL
Stroke; 2008 Jan; 39(1):100-4. PubMed ID: 18063832
[TBL] [Abstract][Full Text] [Related]
15. Increased Serum Alkaline Phosphatase as a Predictor of Symptomatic Hemorrhagic Transformation in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease.
Liu J; Wang D; Li J; Xiong Y; Liu B; Wei C; Wu S; Lin J; Liu M
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2448-52. PubMed ID: 27425768
[TBL] [Abstract][Full Text] [Related]
16. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke.
Rodríguez-Yáñez M; Sobrino T; Arias S; Vázquez-Herrero F; Brea D; Blanco M; Leira R; Castellanos M; Serena J; Vivancos J; Dávalos A; Castillo J
Stroke; 2011 Oct; 42(10):2813-8. PubMed ID: 21836082
[TBL] [Abstract][Full Text] [Related]
17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
18. The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Wang L; Wei C; Deng L; Wang Z; Song M; Xiong Y; Liu M
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1653-1665. PubMed ID: 29598905
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.
Dzialowski I; Pexman JH; Barber PA; Demchuk AM; Buchan AM; Hill MD;
Stroke; 2007 Jan; 38(1):75-9. PubMed ID: 17122437
[TBL] [Abstract][Full Text] [Related]
20. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke.
Paciaroni M; Agnelli G; Caso V; Corea F; Ageno W; Alberti A; Lanari A; Micheli S; Bertolani L; Venti M; Palmerini F; Billeci AM; Comi G; Previdi P; Silvestrelli G
Cerebrovasc Dis; 2009; 28(2):119-23. PubMed ID: 19506370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
